Top Markets
Coin of the day
Kailera Therapeutics, Inc. Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc.

KLRA
Rang in Aktien #5958
Kailera Therapeutics is a biopharmaceutical company currently advancing through... Kailera Therapeutics is a biopharmaceutical company currently advancing through its clinical development stage, dedicated to cultivating a varied portfolio of cutting-edge treatments. These therapeutics are specifically engineered to tackle obesity and its associated metabolic disorders. The company distinguishes itself through its focus on innovative methodologies, offering both injectable and orally administered formulations for sustainable weight management. Its most advanced candidate is a groundbreaking dual-action gut hormone receptor agonist, which has reported encouraging outcomes in its initial clinical investigations.
Aktienkurs
$18.55
Marktkapitalisierung
$2.40B
Veränderung (1 Tag)
0.60%
Veränderung (1 Jahr)
-
Land
US
Handel Kailera Therapeutics, Inc. (KLRA)

Kategorie

Kursverlauf für Kailera Therapeutics, Inc. (KLRA)
Höchster Schlusskurs: $18.15 am 2026-08-01

Niedrigster Schlusskurs: $24.48 am 2026-04-01
Kursverlauf der Aktie von Kailera Therapeutics, Inc. von 2026 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
Nicht genügend Daten für die angegebenen Daten.
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$549.51 41.23%
US
$1.06K 49.60%
NL
$122.63 -12.65%
AU
$139.24 454.72%
US
$765.25 7.19%
CH